IVVD insider trading
HealthcareInvivyd, Inc.: insider trade history from SEC Form 4 filings.
About Invivyd, Inc.
Invivyd, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's pipeline includes PEMGARDA (pemivibart) injection, a half-life extended investigational monoclonal antibody (mAb) for the prevention of COVID-19 in adults and adolescents; VYD2311, an mAb candidate, which is in preclinical studies for the prevention or treatment of COVID-19; and Adintrevimab that is in phase 2/3 clinical trials for the prevention and treatment of COVID-19. It also has discovery stage candidates for the prevention of seasonal influenza and COVID-19. The company has a collaboration agreement with Adimab, LLC for the discovery and optimization of proprietary antibodies. The company was formerly known as Adagio Therapeutics, Inc. and changed its name to Invivyd, Inc. in September 2022. Invivyd, Inc. was incorporated in 2020 and is headquartered in Waltham, Massachusetts.
Company website: invivyd.com
IVVD insider activity at a glance
FilingIQ tracks 63 insider transactions for IVVD in filings since Jan 22, 2024. The most recent transaction is dated Aug 18, 2026.
Across the full history, 1 open-market purchases
and 47 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on IVVD insider trades is 58.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest IVVD Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for IVVD?
- FilingIQ tracks 63 Form 4 insider transactions for IVVD (Invivyd, Inc.), covering filings from Jan 22, 2024 onwards. 15 of those are dated within the last 90 days.
- Are IVVD insiders net buyers or net sellers?
- Across the full Form 4 history for IVVD, 1 transactions (2%) were open-market purchases and 47 (75%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does IVVD insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is IVVD in?
- Invivyd, Inc. (IVVD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $428.62M.
Methodology & sources
Every IVVD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.